70.00
price up icon1.32%   0.91
after-market アフターアワーズ: 69.38 -0.62 -0.89%
loading

Apogee Therapeutics Inc (APGE) 最新ニュース

pulisher
Feb 25, 2026

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million - AOL.com

Feb 25, 2026
pulisher
Feb 25, 2026

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million - The Motley Fool

Feb 25, 2026
pulisher
Feb 24, 2026

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Promising Biotech with Nearly 50% Upside Potential - DirectorsTalk Interviews

Feb 24, 2026
pulisher
Feb 24, 2026

Apogee Therapeutics to Participate in Upcoming March Conferences - The Manila Times

Feb 24, 2026
pulisher
Feb 23, 2026

Apogee Therapeutics (APGE) Expected to Announce Earnings on Monday - Defense World

Feb 23, 2026
pulisher
Feb 22, 2026

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction - Yahoo Finance

Feb 22, 2026
pulisher
Feb 22, 2026

Aberdeen Group plc Takes Position in Apogee Therapeutics Inc. $APGE - MarketBeat

Feb 22, 2026
pulisher
Feb 21, 2026

Apogee Therapeutics Inc. (NASDAQ:APGE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Feb 21, 2026
pulisher
Feb 20, 2026

What is Apogee Therapeutics Inc. s 5 year growth outlookJuly 2025 Rallies & Stock Market Timing Techniques - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Apogee Therapeutics Rings the Closing Bell - Nasdaq

Feb 19, 2026
pulisher
Feb 18, 2026

End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations - Finviz

Feb 18, 2026
pulisher
Feb 18, 2026

Technical Reactions to APGE Trends in Macro Strategies - Stock Traders Daily

Feb 18, 2026
pulisher
Feb 16, 2026

Is Apogee Therapeutics (APGE) Now Defined by Its IL-13/OX40L Positioning Against Sanofi? - Yahoo Finance

Feb 16, 2026
pulisher
Feb 16, 2026

Here is Why Apogee Therapeutics (APGE) Appears Attractive - Yahoo Finance

Feb 16, 2026
pulisher
Feb 16, 2026

CEO Moves: What is Apogee Therapeutics Inc. s 5 year growth outlook2025 Market WrapUp & Weekly Top Gainers Trade List - mfd.ru

Feb 16, 2026
pulisher
Feb 13, 2026

Michael Thomas Henderson Sells 20,000 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Apogee Therapeutics CEO Sells 20,000 Shares - TradingView

Feb 13, 2026
pulisher
Feb 13, 2026

What’s the beta of Apogee Therapeutics Inc. stockTrade Volume Report & Technical Pattern Alert System - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Apogee Therapeutics touts quarterly-to-biannual AD dosing shift, expands asthma ambitions at conference - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Page not foundAirwhon - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

APGE: Quarterly dosing, rapid itch relief, and strong safety set up a 2029 launch to challenge market leaders - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Aug Breakouts: Can Apogee Therapeutics Inc. stock outperform in a bear marketJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Candriam S.C.A. Invests $5.01 Million in Apogee Therapeutics Inc. $APGE - MarketBeat

Feb 12, 2026
pulisher
Feb 11, 2026

Can Apogee Therapeutics Inc. sustain earnings growth2025 Year in Review & Capital Efficient Trade Techniques - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Apogee Therapeutics stock hits 52-week high at 62.24 USD By Investing.com - Investing.com Australia

Feb 10, 2026
pulisher
Feb 09, 2026

Apogee Therapeutics stock hits 52-week high at 62.24 USD - Investing.com

Feb 09, 2026
pulisher
Feb 08, 2026

Smart Money: Should I set a stop loss on Lichen International LimitedEarnings Growth Summary & Weekly Top Gainers Alerts - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 07, 2026

Trading the Move, Not the Narrative: (APGE) Edition - Stock Traders Daily

Feb 07, 2026
pulisher
Feb 07, 2026

Portfolio Update: What is Apogee Therapeutics Incs 5 year growth outlook2025 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 05, 2026

Apogee Therapeutics to Participate at the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times

Feb 05, 2026
pulisher
Feb 04, 2026

Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therap - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

Apogee Therapeutics CMO sells $361,860 in shares By Investing.com - Investing.com Nigeria

Feb 04, 2026
pulisher
Feb 04, 2026

Apogee Therapeutics CMO sells $361,860 in shares - Investing.com

Feb 04, 2026
pulisher
Feb 03, 2026

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A 58.9% Potential Upside for Investors in the Biotech Sector - DirectorsTalk Interviews

Feb 03, 2026
pulisher
Feb 02, 2026

Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns By Investing.com - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns - Investing.com

Feb 02, 2026
pulisher
Jan 29, 2026

What drives Apogee Therapeutics Inc.’s stock priceEarnings Overview Summary & Low Risk Entry Point Tips - mfd.ru

Jan 29, 2026
pulisher
Jan 28, 2026

Fairmount Funds Management LLC Increases Stake in Apogee Therape - GuruFocus

Jan 28, 2026
pulisher
Jan 28, 2026

Aug Gainers: Can Apogee Therapeutics Inc stock outperform in a bear marketWeekly Stock Recap & Long-Term Growth Stock Strategies - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 28, 2026

Exane Asset Management Invests $2.05 Million in Apogee Therapeutics Inc. $APGE - MarketBeat

Jan 28, 2026
$101.27
price up icon 1.18%
$28.94
price up icon 1.58%
$53.57
price up icon 3.60%
$110.23
price up icon 1.31%
$149.33
price down icon 0.45%
biotechnology ONC
$316.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):